Using PET imaging to define esophageal cancer boundaries
Official title: Predicting Esophageal Cancer Borders Using PET-Imaging PEGASUS
Run by University Hospital Heidelberg · NCT06408116 · Data updated 2026-11-12
This study is testing if using advanced imaging techniques can help doctors better see the edges of esophageal tumors in patients before and after treatment to improve surgery and reduce the chance of cancer coming back.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital Heidelberg Academic / other |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 1 site (Heidelberg) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | January 2028 |
| Study ends | April 2028 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT06408116 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus who are planned for surgical treatment.
✕Probably not a fit
Patients with distant metastasis, previous radiation therapy in the tumor region, or those unable to provide consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of endosonography, mpMRI, and PET/CT imaging in accurately determining the boundaries of esophageal tumors before and after neoadjuvant therapy and surgery. It aims to improve the precision of tumor delineation, which is crucial for effective treatment planning in patients with esophageal cancer. By enhancing the accuracy of tumor boundary identification, the study seeks to minimize the risk of cancer recurrence and improve surgical outcomes. The trial is conducted at the University Hospital Heidelberg in Germany, focusing on patients with specific types of esophageal cancer.
Why it matters
Potential benefit: If successful, this approach could lead to more precise treatment planning and improved outcomes for patients with esophageal cancer.
How similar studies have gone: While similar imaging techniques have been explored in other studies, this specific approach using PET imaging for esophageal cancer boundaries is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus, including AEG I and AEG II tumors in the primary situation * Planned surgical treatment of esophageal carcinoma * Possible staging advantage through FAPI PET/CT diagnostics * Patient information and written consent -\> KI 60% or ECOG 0/1 (at least: self-sufficiency) * Age ≥ 18 years Exclusion Criteria: * Previous radiation therapy in the tumor region * Previous tumor disease with \< 5 years of remission * Surgical therapy is not functionally or technically possible * Distant metastasis * Patient is not capable of giving consent * Concurrent participation in another clinical trial that could affect the results of this trial or the other trial * Illnesses that do not allow the person concerned to assess the nature and scope as well as possible consequences of the clinical study * pregnant or breastfeeding women * Signs that the person taking part is unlikely to comply with the therapy (e.g. unwillingness to cooperate)
Where it's running
-
Department of Radiotherapy, University of Heidelberg
Heidelberg, Germany Recruiting
Study contacts
- Study coordinator: Christoph Fink, MD
- Email: christoph.find.@med.uni-heidelberg.de
- Phone: +496221 56
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using virtual reality to help manage pain in GI cancer patients
This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.
-
Are pediatric emergency plans in German children's hospitals ready for disasters?
This study tests whether children's hospitals in Germany have child-specific emergency and response plans and aims to offer recommendations to improve resilience.
-
Gender and Borderline Personality Disorder: a look at relationships and self-view
This study tests how gender identities relate to relationship experiences and self-perception in people with borderline personality disorder.
-
Mentalization-based prevention program to boost well-being for 8–11 year olds and families
A multi-country program tests whether a family-focused, mentalization-based approach can improve well-being and mental health in primary-school children and their parents.
-
Probiotics with or without vitamin B12 added to non-surgical treatment for advanced periodontitis
This study will see if taking a probiotic lozenge alone or together with vitamin B12 during non-surgical periodontal treatment changes the oral microbiome and helps adults with Stage III or IV periodontitis.
-
Same-day ambulatory stroke unit care for older adults with minor stroke or TIA
This trial will try whether same-day ambulatory stroke unit care works as well as inpatient stroke unit care for people aged 60 and older with minor ischemic stroke, transient ischemic attack, or retinal ischemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.